These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 32822814)

  • 1. A-to-I RNA editing as a tuner of noncoding RNAs in cancer.
    Liao Y; Jung SH; Kim T
    Cancer Lett; 2020 Dec; 494():88-93. PubMed ID: 32822814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A-to-I RNA editing - thinking beyond the single nucleotide.
    Ganem NS; Lamm AT
    RNA Biol; 2017 Dec; 14(12):1690-1694. PubMed ID: 28820319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine-to-Inosine RNA Editing Enzyme ADAR and microRNAs.
    Yuting K; Ding D; Iizasa H
    Methods Mol Biol; 2021; 2181():83-95. PubMed ID: 32729076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAR editing in double-stranded UTRs and other noncoding RNA sequences.
    Hundley HA; Bass BL
    Trends Biochem Sci; 2010 Jul; 35(7):377-83. PubMed ID: 20382028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine-to-inosine RNA editing.
    Zinshteyn B; Nishikura K
    Wiley Interdiscip Rev Syst Biol Med; 2009; 1(2):202-209. PubMed ID: 20835992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A-to-I RNA editing and cancer: from pathology to basic science.
    Gallo A; Galardi S
    RNA Biol; 2008; 5(3):135-9. PubMed ID: 18758244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript.
    Wheeler EC; Washburn MC; Major F; Rusch DB; Hundley HA
    RNA Biol; 2015; 12(2):162-74. PubMed ID: 25826568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A-to-I editing of protein coding and noncoding RNAs.
    Mallela A; Nishikura K
    Crit Rev Biochem Mol Biol; 2012; 47(6):493-501. PubMed ID: 22988838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
    Ganem NS; Ben-Asher N; Lamm AT
    Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide quantification of ADAR adenosine-to-inosine RNA editing activity.
    Roth SH; Levanon EY; Eisenberg E
    Nat Methods; 2019 Nov; 16(11):1131-1138. PubMed ID: 31636457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAR-mediated RNA editing in non-coding RNA sequences.
    Yang Y; Zhou X; Jin Y
    Sci China Life Sci; 2013 Oct; 56(10):944-52. PubMed ID: 24008387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When MicroRNAs Meet RNA Editing in Cancer: A Nucleotide Change Can Make a Difference.
    Wang Y; Liang H
    Bioessays; 2018 Feb; 40(2):. PubMed ID: 29280160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms and implications of ADAR-mediated RNA editing in cancer.
    Wang C; Zou J; Ma X; Wang E; Peng G
    Cancer Lett; 2017 Dec; 411():27-34. PubMed ID: 28974449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testicular adenosine to inosine RNA editing in the mouse is mediated by ADARB1.
    Snyder EM; Licht K; Braun RE
    Biol Reprod; 2017 Jan; 96(1):244-253. PubMed ID: 28395340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-selective versus promiscuous A-to-I editing.
    Wahlstedt H; Ohman M
    Wiley Interdiscip Rev RNA; 2011; 2(6):761-71. PubMed ID: 21976281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome-wide identification of A > I RNA editing sites by inosine specific cleavage.
    Cattenoz PB; Taft RJ; Westhof E; Mattick JS
    RNA; 2013 Feb; 19(2):257-70. PubMed ID: 23264566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale prediction of ADAR-mediated effective human A-to-I RNA editing.
    Yao L; Wang H; Song Y; Dai Z; Yu H; Yin M; Wang D; Yang X; Wang J; Wang T; Cao N; Zhu J; Shen X; Song G; Zhao Y
    Brief Bioinform; 2019 Jan; 20(1):102-109. PubMed ID: 28968662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
    Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
    RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of widespread ultra-edited human RNAs.
    Carmi S; Borukhov I; Levanon EY
    PLoS Genet; 2011 Oct; 7(10):e1002317. PubMed ID: 22028664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered adenosine-to-inosine RNA editing in human cancer.
    Paz N; Levanon EY; Amariglio N; Heimberger AB; Ram Z; Constantini S; Barbash ZS; Adamsky K; Safran M; Hirschberg A; Krupsky M; Ben-Dov I; Cazacu S; Mikkelsen T; Brodie C; Eisenberg E; Rechavi G
    Genome Res; 2007 Nov; 17(11):1586-95. PubMed ID: 17908822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.